C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2011
06/08/2011	CN101044139B Cyclopamine analogues and methods of use thereof
06/07/2011	US7956194 Microbiocidal (E.G. fungicidal) 1,2,3-triazole derivatives
06/07/2011	US7956187 Method for decreasing opioid metabolism
06/07/2011	US7956075 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain.
06/07/2011	US7956060 Pyrimidine derivative compound
06/07/2011	US7956058 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
06/07/2011	US7956053 Inhibitors of tyrosine kinases
06/07/2011	CA2562130C 2-propene-1-ones as hsp 70 inducers
06/03/2011	WO2011066352A1 An amorphous and a crystalline form of genz 112638 hemitartrat as inhibitor of glucosylceramide synthase
06/03/2011	WO2011066183A1 Novel spiropiperidine compounds
06/03/2011	WO2011066179A1 Novel compounds as receptor modulators with therapeutic utility
06/03/2011	WO2011066168A1 Potassium channel modulators
06/03/2011	WO2011065545A1 5-FLUOROURACIL COMPOUND HAVING dUTPase-INHIBITING ACTIVITY OR SALT THEREOF
06/03/2011	WO2011065541A1 Anti-tumor effect potentiator
06/03/2011	WO2011065402A1 Indole compound and pharmaceutical use thereof
06/03/2011	WO2011064249A1 Synthesis of acetoxyacetaldehyde
06/03/2011	WO2011044506A3 Sulphone compounds for use in the treatment of obesity
06/03/2011	CA2782280A1 Anti-tumor effect potentiator
06/03/2011	CA2781676A1 An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
06/03/2011	CA2781660A1 Indole compound and pharmaceutical use thereof
06/03/2011	CA2781292A1 Novel spiropiperidine compounds
06/03/2011	CA2780908A1 Novel compounds as receptor modulators with therapeutic utility
06/03/2011	CA2778266A1 Potassium channel modulators
06/02/2011	US20110130559 Methods to Manufacture 1,3-Dioxolane Nucleosides
06/02/2011	US20110130426 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
06/02/2011	US20110130415 Protein kinase c inhibitors and uses thereof
06/02/2011	US20110130399 Phthalazine Derivatives with Angiogenesis Inhibiting Activity
06/02/2011	US20110130397 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
06/02/2011	US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
06/02/2011	US20110130380 Heteroaryl Kinase Inhibitors
06/02/2011	US20110130363 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
06/02/2011	US20110130288 Novel solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5h)-one
06/02/2011	US20110129878 Bioreactive agents
06/02/2011	US20110129419 In vivo imaging agents
06/01/2011	EP2327701A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
06/01/2011	EP2327700A1 Dialkyl triazinamines and use thereof for combating undesired plant growth
06/01/2011	EP2327690A1 Tricyclic compound
06/01/2011	EP2327683A1 Synthesis of acetoxyacetaldehyde
06/01/2011	EP2327682A1 Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
06/01/2011	EP2327304A1 Use of substituted enaminocarbonyl compounds for combating animal pests
06/01/2011	EP2326642A2 Salt of, and processes for the preparation of, 1-isopropyl-4-{[4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine
06/01/2011	EP2326640A1 Pyrrole carboxylic acid derivatives as antibacterial agents
06/01/2011	EP2326634A1 Chromene modulators of chemokine receptor activity
06/01/2011	EP2326633A1 Compounds for the treatment of hepatitis c
06/01/2011	EP2326627A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
06/01/2011	EP2326625A1 Benzazepine derivatives and their use as hstamine h3 antagonists
06/01/2011	EP2326623A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
06/01/2011	EP2326622A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
06/01/2011	EP1981854B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
06/01/2011	EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers
06/01/2011	CN1934103B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
06/01/2011	CN102083823A Method for producing 1-biphenylmethylimidazole compound
06/01/2011	CN102083811A 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
06/01/2011	CN102083799A Benzimidazole derivatives used as FXR agonists
06/01/2011	CN102083794A Urea compounds as gamma secretase modulators
06/01/2011	CN102079747A Olmesartan medoxomil key intermediate, synthesis method thereof and method for synthesizing olmesartan medoxomil from same
06/01/2011	CN102079744A Deuterated achiral crizotinib and derivatives, preparation method and application thereof
06/01/2011	CN102079727A Novel processes for the preparation of a 2h-chromene
06/01/2011	CN102079726A Miazine compounds, intermediates of miazine compounds, preparation method of intermediates and miazine compounds as well as application of miazine compound
05/2011
05/31/2011	US7951958 Imidazole compounds for the treatment of neurodegenerative disorders
05/31/2011	US7951830 Compounds effecting glucokinase
05/31/2011	US7951822 1,3-dihydroisobenzofuran derivatives
05/31/2011	US7951820 Triazole compounds useful as protein kinase inhibitors
05/31/2011	US7951809 Inhibitors of p38
05/31/2011	US7951752 O-cyclopropyl-carboxanilides and their use as fungicides
05/31/2011	CA2507657C 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
05/31/2011	CA2475764C New inhibitors of histone deacetylase
05/31/2011	CA2319080C Multivalent antibacterial agents
05/26/2011	WO2011063233A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
05/26/2011	WO2011062437A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
05/26/2011	WO2011062194A1 Aminopyridine derivative
05/26/2011	WO2011061330A2 Use of physiological cooling active ingredients, and agents containing such active ingredients
05/26/2011	WO2011061168A1 Aryl-pyridine derivatives as aldosterone synthase inhibitors
05/26/2011	WO2011061139A1 Substituted pyrrolidine-2-carboxamides
05/26/2011	WO2011060873A1 Quinazoline derivatives
05/26/2011	WO2011060859A1 Materials for organic electroluminescent devices
05/26/2011	WO2009141837A3 Process for preparing posaconazole and intermediates thereof
05/26/2011	WO2009138999A3 Process for the preparation of paroxetine hydrochloride
05/26/2011	US20110124870 Novel mycobacterial inhibitors
05/26/2011	US20110124703 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes
05/26/2011	US20110124674 5/5-or 5/6-membered condensed ring cycloalkylamine derivative
05/26/2011	US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
05/26/2011	US20110124669 Modulators of Cellular Adhesion
05/26/2011	US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group
05/26/2011	US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
05/26/2011	US20110124633 Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy
05/26/2011	US20110124628 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/26/2011	US20110124625 Modulators of Cellular Adhesion
05/26/2011	US20110124622 Isoindolones derivatives as mek kinase inhibitors and methods of use
05/26/2011	US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
05/26/2011	US20110123490 Heterocyclic antiviral compounds
05/26/2011	US20110122475 Photochromic dichroic naphtho-pyrans and optical articles containing them
05/26/2011	CA2781380A1 Quinazoline derivatives
05/26/2011	CA2778867A1 Substituted pyrrolidine-2-carboxamides
05/25/2011	EP2325183A1 4-(2-Furoyl) Aminopiperidine compound useful as therapeutic agent for itching
05/25/2011	EP2325182A1 Bicyclic compounds and use as antidiabetics
05/25/2011	EP2325180A1 Chiral CIS-imidazolines
05/25/2011	EP2325179A1 Glycosidase ihhibitors and preparation thereof
05/25/2011	EP2325175A1 2,4-diaminopyrimidine compound
05/25/2011	EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage

1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 694